https://pharminent.com/market-access/market-access-intelligence-weekly-digest-august-14-2026/ 2026-08-15T15:18:13Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • August 14, 2026 2026-08-15T15:18:11Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-august-14-2026/ 2026-08-15T15:15:21Z Pharminent en Oncology Intelligence Digest • August 14, 2026 2026-08-15T15:15:19Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-august-14-2026/ 2026-08-15T15:13:53Z Pharminent en GLP-1 Competitive Market Digest • Weekly • August 14, 2026 2026-08-15T15:13:50Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-august-13-2026/ 2026-08-15T15:11:40Z Pharminent en Rare Disease & Gene Therapy Digest • August 13, 2026 2026-08-15T15:11:38Z Blog https://pharminent.com/bms-wins-first-fda-approval-for-celmod-class-with-zenbexus-in-multiple-myeloma/ 2026-08-14T19:35:32Z Pharminent en BMS Wins First FDA Approval for CELMoD Class With Zenbexus in Multiple Myeloma 2026-08-14T19:35:28Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-14-2026/ 2026-08-14T16:45:59Z Pharminent en Strategic News Watch • August 14, 2026 2026-08-14T16:45:56Z Blog